Results 31 to 40 of about 183,686 (358)
An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening
Current Protocols in Microbiology, 2020 The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) emerged in the city of Wuhan, Hubei Province, China, in late 2019. Since then, the virus has spread globally and caused a pandemic.
F. Amanat +12 more
semanticscholar +1 more source
Diagnostics, 2021 Ovarian cancer remains a major diagnostic and therapeutic problem in modern gynecological oncology. For this reason, research which focuses on the search for new diagnostic markers and the assessment of their possible usefulness in clinical practice is ...
Aleksandra Mielczarek-Palacz +2 more
doaj +1 more source
A systematic review of maternal TORCH serology as a screen for suspected fetal infection
Prenatal Diagnosis, 2021 The acronym ‘TORCH’ refers to well‐recognised causes of perinatal infections: toxoplasmosis, rubella, cytomegalovirus (CMV) and herpes simplex virus (HSV). A TORCH serology panel is often used to test for maternal primary infection following detection of
D. Fitzpatrick, N. Holmes, L. Hui
semanticscholar +1 more source
Pteridines, 2004 Endometriosis is a gynaecological disorder characterized by increased number and activation of peritoneal macrophages and release of macrophage-derived cytokines and growth factors. The aim of our work was t(5 study the level of neopterin and interleukin
Kondera-Anasz Zdzislawa +4 more
doaj +1 more source
Genomic analysis of Neisseria elongata isolate from a patient with infective endocarditis
FEBS Open Bio, 2021 Neisseria elongata is part of the commensal microbiota of the oropharynx. Although it is not considered pathogenic to humans, N. elongata has been implicated in several cases of infective endocarditis (IE).
Marcos André Schörner +7 more
doaj +1 more source
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward
Science immunology, 2020 Defining acceptable performance characteristics for SARS-CoV-2 serological tests requires factoring in how the results will be used. Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts.
Juliet E. Bryant +13 more
semanticscholar +1 more source
Challenges of Rabies Serology: Defining Context of Interpretation
Viruses, 2021 The case fatality rate of rabies, nearly 100%, is one of the most unique characteristic of this ancient virus infection. The crucial role rabies virus neutralizing antibody plays in protection is both well established and explanation of why rabies ...
S. Moore
semanticscholar +1 more source
COVID, 2021 This review explores and positions the value of serology testing to support current immunization policies and the broader policy response to the coronavirus disease 2019 (COVID-19) crisis in Europe.
P. Bonanni +7 more
semanticscholar +1 more source
British Journal of Dermatology, 2020 Acral lesions, mainly chilblains, are the most frequently reported cutaneous lesions associated with COVID‐19. In more than 80% of patients tested, nasopharyngeal swabs were negative on reverse transcription polymerase chain reaction (RT‐PCR) for SARS ...
L. L. Cleach +20 more
semanticscholar +1 more source
Cells, 2020 Due to the ability to selectively induce apoptosis in cancer cells, the most interesting target for clinical research is the tumour necrosis factor ligand inducing apoptosis (TRAIL), which binds specific receptors, including osteoprotegerin (OPG).
Aleksandra Mielczarek-Palacz +2 more
doaj +1 more source